Asst. Prof. Dr. Pipit Burasakarn

Consultant

25 Years of Experience

Hepatologist

MD, PhD

Vejthani Hospital, Bangkok

English, Thai

Consultation Fee $ 24

Book an Appointment

About Asst. Prof. Dr. Pipit Burasakarn

Dr. Pipit Burasakarn is a Hepatobiliary Surgeon with 25 years of experience.
His expertise lies in diagnosing and managing disorders of the gallbladder, liver, and pancreas. He treats cancers and stones of these organs.
Dr. Burasakarn's qualifications include an MD from Phramongkutklao College of Medicine, Thailand, in 2009 and a PhD from Tokyo Women’s Medical University Hospital, Japan, in 2021. He was certified in General Surgery from the same college in 2015.
Dr. Burasakarn is board-certified in Hepato-Pancreato-Biliary Surgery from both Oita University Hospital and Tokyo Women’s Medical University Hospital of Japan.
Beyond clinical practice, he has also published 14 scientific papers in reputed journals, such as The American Surgeon, International Journal of Gastrointestinal Intervention, and Innovative Surgical Sciences.
He is an active member of the Royal College of Surgeons of Thailand.

Book Your Appointment With Asst. Prof. Dr. Pipit Burasakarn

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MD, Phramongkutklao College of Medicine, Bangkok, Thailand, 2009
PhD, Tokyo Women’s Medical University Hospital, Tokyo, Japan, 2021

Training & Certificates

Certificate for General Surgery, Phramongkutklao Hospital, Bangkok, Thailand, 2015
Certificate for Hepato-Pancreato-Biliary Surgery, Oita University Hospital, Oita, Japan, 2017
Certificate for Hepato-Pancreato-Biliary Surgery, Tokyo Women’s Medical University Hospital, Tokyo, Japan, 2018

Associations/Membership

Royal College of Surgeons of Thailand

Paper Published

Dr. Pipit Burasakarn has 14 scientific publications in his name.

Polvieng, Thanatchawan & Hongjinda, Sermsak & Thienhiran, Anuparp & Burasakarn, Pipit & Fuengfoo, Pusit. (2024). Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection. The American surgeon. 90. 31348241241713. 10.1177/00031348241241713.
Burasakarn, Pipit & Yochum, Kwanchanok & Hongjinda, Sermsak & Thienhiran, Anuparp & Fuengfoo, Pusit. (2023). Analysis of risk factors associated with distant metastasis detected at laparotomy in patients with radiologically resectable pancreatic ductal adenocarcinoma. Surgical Practice. 28. 10.1111/1744-1633.12669.
Burasakarn, Pipit & Hongjinda, Sermsak & Thienhiran, Anuparp & Phancharoenkit, Nichaphat & Fuengfoo, Pusit. (2023). Preoperative transarterial chemoembolization does not improve the outcomes of resectable hepatocellular carcinoma: A propensity score-matched study. International Journal of Gastrointestinal Intervention. 12. 169-175. 10.18528/ijgii230025.
Burasakarn, Pipit & Hongjinda, Sermsak & Fuengfoo, Pusit & Thienhiran, Anuparp. (2023). Neoadjuvant chemotherapy vs. upfront surgery for resectable colorectal liver metastases: a systemic review and meta?analysis. Surgical Practice. 28. 10.1111/1744-1633.12662.
Phancharoenkit, Nichaphat & Thienhiran, Anuparp & Burasakarn, Pipit & Fuengfoo, Pusit & Hongjinda, Sermsak. (2023). Acute cholangitis caused by a huge hepatic simple cyst: a case report. Journal of Surgical Case Reports. 2023. 10.1093/jscr/rjad056.
Burasakarn, Pipit & Thienhiran, Anuparp & Fuengfoo, Pusit & Hongjinda, Sermsak. (2022). Analysis of preoperative risk factors for early recurrence after curative pancreatoduodenectomy for resectable pancreatic adenocarcinoma. Innovative surgical sciences. 7. 5-11. 10.1515/iss-2021-0034.